126 related articles for article (PubMed ID: 37905063)
1. An inducible ESCRT-III inhibition tool to control HIV-1 budding.
Wang H; Gallet B; Moriscot C; Pezet M; Chatellard C; Kleman JP; Göttlinger H; Weissenhorn W; Boscheron C
bioRxiv; 2023 Oct; ():. PubMed ID: 37905063
[TBL] [Abstract][Full Text] [Related]
2. An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding.
Wang H; Gallet B; Moriscot C; Pezet M; Chatellard C; Kleman JP; Göttlinger H; Weissenhorn W; Boscheron C
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140530
[TBL] [Abstract][Full Text] [Related]
3. ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
Effantin G; Dordor A; Sandrin V; Martinelli N; Sundquist WI; Schoehn G; Weissenhorn W
Cell Microbiol; 2013 Feb; 15(2):213-26. PubMed ID: 23051622
[TBL] [Abstract][Full Text] [Related]
4. ESCRT requirements for EIAV budding.
Sandrin V; Sundquist WI
Retrovirology; 2013 Oct; 10():104. PubMed ID: 24107264
[TBL] [Abstract][Full Text] [Related]
5. ESCRT-III protein requirements for HIV-1 budding.
Morita E; Sandrin V; McCullough J; Katsuyama A; Baci Hamilton I; Sundquist WI
Cell Host Microbe; 2011 Mar; 9(3):235-242. PubMed ID: 21396898
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of the endosomal sorting required for transport complex III pathway genes as therapeutic and prognostic biomarkers for endometrial carcinoma.
Yang Y; Wang M
Transl Cancer Res; 2022 Sep; 11(9):3108-3127. PubMed ID: 36237250
[TBL] [Abstract][Full Text] [Related]
7. Super-resolution imaging of ESCRT-proteins at HIV-1 assembly sites.
Prescher J; Baumgärtel V; Ivanchenko S; Torrano AA; Bräuchle C; Müller B; Lamb DC
PLoS Pathog; 2015 Feb; 11(2):e1004677. PubMed ID: 25710462
[TBL] [Abstract][Full Text] [Related]
8. High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle budding.
Gupta S; Bromley J; Saffarian S
PLoS One; 2020; 15(9):e0237268. PubMed ID: 32886660
[TBL] [Abstract][Full Text] [Related]
9. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters.
Carlson LA; Hurley JH
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16928-33. PubMed ID: 23027949
[TBL] [Abstract][Full Text] [Related]
10. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding.
Zamborlini A; Usami Y; Radoshitzky SR; Popova E; Palu G; Göttlinger H
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19140-5. PubMed ID: 17146056
[TBL] [Abstract][Full Text] [Related]
11. ESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplasts.
Norgan AP; Lee JR; Oestreich AJ; Payne JA; Krueger EW; Katzmann DJ
PLoS One; 2012; 7(12):e52603. PubMed ID: 23285107
[TBL] [Abstract][Full Text] [Related]
12. ESCRT Requirements for Murine Leukemia Virus Release.
Bartusch C; Prange R
Viruses; 2016 Apr; 8(4):103. PubMed ID: 27096867
[TBL] [Abstract][Full Text] [Related]
13. Temporal and spatial organization of ESCRT protein recruitment during HIV-1 budding.
Bleck M; Itano MS; Johnson DS; Thomas VK; North AJ; Bieniasz PD; Simon SM
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12211-6. PubMed ID: 25099357
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding.
Sette P; Nagashima K; Piper RC; Bouamr F
Retrovirology; 2013 Jul; 10():79. PubMed ID: 23895345
[TBL] [Abstract][Full Text] [Related]
15. Distribution of ESCRT machinery at HIV assembly sites reveals virus scaffolding of ESCRT subunits.
Van Engelenburg SB; Shtengel G; Sengupta P; Waki K; Jarnik M; Ablan SD; Freed EO; Hess HF; Lippincott-Schwartz J
Science; 2014 Feb; 343(6171):653-6. PubMed ID: 24436186
[TBL] [Abstract][Full Text] [Related]
16. Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component.
Baumgärtel V; Ivanchenko S; Dupont A; Sergeev M; Wiseman PW; Kräusslich HG; Bräuchle C; Müller B; Lamb DC
Nat Cell Biol; 2011 Apr; 13(4):469-74. PubMed ID: 21394086
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of ESCRT-III.
Lata S; Schoehn G; Solomons J; Pires R; Göttlinger HG; Weissenhorn W
Biochem Soc Trans; 2009 Feb; 37(Pt 1):156-60. PubMed ID: 19143622
[TBL] [Abstract][Full Text] [Related]
18. Human ESCRT-III polymers assemble on positively curved membranes and induce helical membrane tube formation.
Bertin A; de Franceschi N; de la Mora E; Maity S; Alqabandi M; Miguet N; di Cicco A; Roos WH; Mangenot S; Weissenhorn W; Bassereau P
Nat Commun; 2020 May; 11(1):2663. PubMed ID: 32471988
[TBL] [Abstract][Full Text] [Related]
19. VPS4 triggers constriction and cleavage of ESCRT-III helical filaments.
Maity S; Caillat C; Miguet N; Sulbaran G; Effantin G; Schoehn G; Roos WH; Weissenhorn W
Sci Adv; 2019 Apr; 5(4):eaau7198. PubMed ID: 30989108
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Gag release from yeast reveals ESCRT interaction with the Gag N-terminal protein region.
Meusser B; Purfuerst B; Luft FC
J Biol Chem; 2020 Dec; 295(52):17950-17972. PubMed ID: 32994219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]